anonymous
Guest
anonymous
Guest
Classic Pharma playbook...how many drugs at end of their patent life all of sudden get a pediatric indication at the last minute...next play will be to sue every generic maker (company knows they'll lose but paying a few million in lawyers is bargain in continuing to make profit) .. after that we'll turn around and sell our generic version for few cents less than the other guys ...